Fertility rate, total (births per woman) in United States was reported at 1.6165 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Fertility rate, total (births per woman) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Birth rate, crude (per 1,000 people) in United States was reported at 10.7 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Birth rate, crude - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The total fertility rate of the world has dropped from around 5 children per woman in 1950, to 2.2 children per woman in 2025, which means that women today are having fewer than half the number of children that women did 75 years ago. Replacement level fertility This change has come as a result of the global demographic transition, and is influenced by factors such as the significant reduction in infant and child mortality, reduced number of child marriages, increased educational and vocational opportunities for women, and the increased efficacy and availability of contraception. While this change has become synonymous with societal progress, it does have wide-reaching demographic impact - if the global average falls below replacement level (roughly 2.1 children per woman), as is expected to happen in the 2050s, then this will lead to long-term population decline on a global scale. Regional variations When broken down by continent, Africa is the only region with a fertility rate above the global average, and, alongside Oceania, it is the only region with a fertility rate above replacement level. Until the 1980s, the average woman in Africa could expect to have 6-7 children over the course of their lifetime, and there are still several countries in Africa where women can still expect to have 5 or more children in 2025. Historically, Europe has had the lowest fertility rates in the world over the past century, falling below replacement level in 1975. Europe's population has grown through a combination of migration and increasing life expectancy, however even high immigration rates could not prevent its population from going into decline in 2021.

Adolescent fertility rate (births per 1,000 women ages 15-19) in United States was reported at 13.14 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Adolescent fertility rate (births per 1,000 women ages 15-19) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

This statistic shows the fertility rate worldwide from 1975 to 2100. By 2100, the worldwide fertility rate is projected to be an average of 1.94 children per woman.

Introduction

This report presents projections of population from 2015 to 2025 by age and sex for Illinois, Chicago and Illinois counties produced for the Certificate of Need (CON) Program. As actual future population trends are unknown, the projected numbers should not be considered a precise prediction of the future population; rather, these projections, calculated under a specific set of assumptions, indicate the levels of population that would result if our assumptions about each population component (births, deaths and net migration) hold true. The assumptions used in this report, and the details presented below, generally assume a continuation of current trends.

Methodology These projections were produced using a demographic cohort-component projection model. In this model, each component of population change – birth, death and net migration – is projected separately for each five-year birth cohort and sex. The cohort – component method employs the following basic demographic balancing equation: P1 = P0 + B – D + NM Where: P1 = Population at the end of the period; P0 = Population at the beginning of the period; B = Resident births during the period; D = Resident deaths during the period; and NM = Net migration (Inmigration – Outmigration) during the period. The model roughly works as follows: for every five-year projection period, the base population, disaggregated by five-year age groups and sex, is “survived” to the next five-year period by applying the appropriate survival rates for each age and sex group; next, net migrants by age and sex are added to the survived population. The population under 5 years of age is generated by applying age specific birth rates to the survived females in childbearing age (15 to 49 years).

Base Population These projections began with the July 1, 2010 population estimates by age and sex produced by the U.S. Census Bureau. The most recent census population of April 1, 2010 was the base for July 1, 2010 population estimates.

Special Populations In 19 counties, the college dormitory population or adult inmates in correctional facilities accounted for 5 percent or more of the total population of the county; these counties were considered as special counties. There were six college dorm counties (Champaign, Coles, DeKalb, Jackson, McDonough and McLean) and 13 correctional facilities counties (Bond, Brown, Crawford, Fayette, Fulton, Jefferson, Johnson, Lawrence, Lee, Logan, Montgomery, Perry and Randolph) that qualified as special counties. When projecting the population, these special populations were first subtracted from the base populations for each special county; then they were added back to the projected population to produce the total population projections by age and sex. The base special population by age and sex from the 2010 population census was used for this purpose with the assumption that this population will remain the same throughout each projection period.

Mortality Future deaths were projected by applying age and sex specific survival rates to each age and sex specific base population. The assumptions on survival rates were developed on the basis of trends of mortality rates in the individual life tables constructed for each level of geography for 1989-1991, 1999-2001 and 2009-2011. The application of five-year survival rates provides a projection of the number of persons from the initial population expected to be alive in five years. Resident deaths data by age and sex from 1989 to 2011 were provided by the Illinois Center for Health Statistics (ICHS), Illinois Department of Public Health.

Fertility Total fertility rates (TFRs) were first computed for each county. For most counties, the projected 2015 TFRs were computed as the average of the 2000 and 2010 TFRs. 2010 or 2015 rates were retained for 2020 projections, depending on the birth trend of each county. The age-specific birth rates (ASBR) were next computed for each county by multiplying the 2010 ASBR by each projected TFR. Total births were then projected for each county by applying age-specific birth rates to the projected female population of reproductive ages (15 to 49 years). The total births were broken down by sex, using an assumed sex-ratio at birth. These births were survived five years applying assumed survival ratios to get the projected population for the age group 0-4. For the special counties, special populations by age and sex were taken out before computing age-specific birth rates. The resident birth data used to compute age-specific birth rates for 1989-1991, 1999-2001 and 2009-2011 came from ICHS. Births to females younger than 15 years of age were added to those of the 15-19 age group and births to women older than 49 years of age were added to the 45-49 age group.

Net Migration Migration is the major component of population change in Illinois, Chicago and Illinois counties. The state is experiencing a significant loss of population through internal (domestic migration within the U.S.) net migration. Unlike data on births and deaths, migration data based on administrative records are not available on a regular basis. Most data on migration are collected through surveys or indirectly from administrative records (IRS individual tax returns). For this report, net migration trends have been reviewed using data from different sources and methods (such as residual method) from the University of Wisconsin, Madison, Illinois Department of Public Health, individual exemptions data from the Internal Revenue Service, and survey data from the U.S. Census Bureau. On the basis of knowledge gained through this review and of levels of net migration from different sources, assumptions have been made that Illinois will have annual net migrants of -40, 000, -35,000 and -30,000 during 2010-2015, 2015-2020 and 2020-2025, respectively. These figures have been distributed among the counties, using age and sex distribution of net migrants during 1995-2000. The 2000 population census was the last decennial census, which included the question “Where did you live five years ago?” The age and sex distribution of the net migrants was derived, using answers to this question. The net migration for Chicago has been derived independently, using census survival method for 1990-2000 and 2000-2010 under the assumption that the annual net migration for Chicago will be -40,000, -30,000 and -25,000 for 2010-2015, 2015-2020 and 2020-2025, respectively. The age and sex distribution from the 2000-2010 net migration was used to distribute the net migrants for the projection periods.

Conclusion These projections were prepared for use by the Certificate of Need (CON) Program; they are produced using evidence-based techniques, reasonable assumptions and the best available input data. However, as assumptions of future demographic trends may contain errors, the resulting projections are unlikely to be free of errors. In general, projections of small areas are less reliable than those for larger areas, and the farther in the future projections are made, the less reliable they may become. When possible, these projections should be regularly reviewed and updated, using more recent birth, death and migration data.

According to Cognitive Market Research, the Global IVF Services Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

The IVF Services market will expand significantly by XX% CAGR between 2024 and 2031.
The female infertility segment accounts for the largest market share and is anticipated to a healthy growth over the approaching years.
The product equipment segment accounts for the largest market share and is anticipated to a healthy growth over the approaching years.
The usage of Fresh Cycle IVF Services holds the largest market share compared to others.
Application of IVF Services in the Fertility Clinics segment is the market’s largest contributor and is anticipated to expand at a CAGR of XX% during the projected period.
The ICSI IVF procedure holds the largest market share compared to others.
Asia Pacific region dominated the market and accounted for the highest revenue of XX% in 2022 and it is projected that it will grow at a CAGR of XX% in the future.

Market Dynamics of the IVF Service Market

Key Drivers of the IVF Service Market

The rise in infertility cases is driving the market for IVF Services.

Infertility is a serious health issue worldwide, affecting almost 8 to 10% of couples globally. Nearly 60-80 million couples suffer from infertility every year globally. (Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881900/)

Physical issues and lifestyle choices both can affect the ability to conceive. Age, physical health, and lifestyle choices, such as smoking and diet, can contribute to a person’s fertility irrespective of gender. Approximately one in eight couples are affected by infertility in the United States accounting for around 6.7 million people each year. Also, the natural fertility rate is only 20%. One of the main reasons behind this is that fertility begins to decline at about 35 years (Source: https://www.fertilityanswers.com/13-stats-know-infertility/#:~:text=Approximately%20one%20in%20eight%20couples,year%20who%20have%20trouble%20conceiving.)

The rising number of infertility cases is leading people to consult and opt for IVF services as it is considered the most effective type of fertility treatment.

The growth in the median age of first-time mothers is raising the demand for IVF services.

Delayed childbearing is currently a major challenge in reproductive medicine as increased age has an important impact on successful conception, both in natural and assisted reproduction. Women have increasingly postponed their first childbirth until later in life. This is because of many reasons like higher education, career opportunities, delaying marriage, and growing acceptance of unmarried women having children. As a result, the average age of first-time mothers has risen to 28 years whereas some wait even longer. Birth rates for women in their 30s are at an all-time high; however, studies state that with age, fertility in women declines, and this decline becomes more significant after 35 years of age and gives rise to risks of pregnancy complications.

Couples who struggle with infertility often shift to IVF as an assisted reproductive method. The IVF success rates under 35 are encouraging and offer hope to couples struggling with infertility because of late-age pregnancy. As more couples seek fertility treatments to conceive, this is in turn raising the demand for IVF services.

Key Restraints of the IVF Service Market

Health concerns related to IVF treatment can restrict the market growth. 

Fertility treatments are generally very safe; however, all medical procedures carry some chances of certain health problems. Sometimes, IVF can be draining for the body, mind, and finances and also can create complications from the procedure to retrieve eggs. Also, IVF raises the risk of having more than one baby, and becoming pregnant with multiple babies carries higher risks of pregnancy-related high blood pressure and diabetes, early labor and delivery, low birth weight, and birth defects compared to a single baby. In cases where more than one fetus develops, the health risks for both babies and the mother will increase.

The other side effects of IVF can include soreness or bruising from injections, nausea, breast tenderness, bloating, hot flashes, miscarriage, mood swings,...

In the past four centuries, the population of the Thirteen Colonies and United States of America has grown from a recorded 350 people around the Jamestown colony in Virginia in 1610, to an estimated 346 million in 2025. While the fertility rate has now dropped well below replacement level, and the population is on track to go into a natural decline in the 2040s, projected high net immigration rates mean the population will continue growing well into the next century, crossing the 400 million mark in the 2070s. Indigenous population Early population figures for the Thirteen Colonies and United States come with certain caveats. Official records excluded the indigenous population, and they generally remained excluded until the late 1800s. In 1500, in the first decade of European colonization of the Americas, the native population living within the modern U.S. borders was believed to be around 1.9 million people. The spread of Old World diseases, such as smallpox, measles, and influenza, to biologically defenseless populations in the New World then wreaked havoc across the continent, often wiping out large portions of the population in areas that had not yet made contact with Europeans. By the time of Jamestown's founding in 1607, it is believed the native population within current U.S. borders had dropped by almost 60 percent. As the U.S. expanded, indigenous populations were largely still excluded from population figures as they were driven westward, however taxpaying Natives were included in the census from 1870 to 1890, before all were included thereafter. It should be noted that estimates for indigenous populations in the Americas vary significantly by source and time period. Migration and expansion fuels population growth The arrival of European settlers and African slaves was the key driver of population growth in North America in the 17th century. Settlers from Britain were the dominant group in the Thirteen Colonies, before settlers from elsewhere in Europe, particularly Germany and Ireland, made a large impact in the mid-19th century. By the end of the 19th century, improvements in transport technology and increasing economic opportunities saw migration to the United States increase further, particularly from southern and Eastern Europe, and in the first decade of the 1900s the number of migrants to the U.S. exceeded one million people in some years. It is also estimated that almost 400,000 African slaves were transported directly across the Atlantic to mainland North America between 1500 and 1866 (although the importation of slaves was abolished in 1808). Blacks made up a much larger share of the population before slavery's abolition. Twentieth and twenty-first century The U.S. population has grown steadily since 1900, reaching one hundred million in the 1910s, two hundred million in the 1960s, and three hundred million in 2007. Since WWII, the U.S. has established itself as the world's foremost superpower, with the world's largest economy, and most powerful military. This growth in prosperity has been accompanied by increases in living standards, particularly through medical advances, infrastructure improvements, clean water accessibility. These have all contributed to higher infant and child survival rates, as well as an increase in life expectancy (doubling from roughly 40 to 80 years in the past 150 years), which have also played a large part in population growth. As fertility rates decline and increases in life expectancy slows, migration remains the largest factor in population growth. Since the 1960s, Latin America has now become the most common origin for migrants in the U.S., while immigration rates from Asia have also increased significantly. It remains to be seen how immigration restrictions of the current administration affect long-term population projections for the United States.

Snapshot img

Fertility Services Market Size 2025-2029

The fertility services market size is forecast to increase by USD 9.53 billion, at a CAGR of 7.8% between 2024 and 2029.

The market is a continually evolving landscape, driven by various factors that shape its dynamics. One significant trend is the increasing demand for fertility treatments due to the rising prevalence of late parenthood. According to recent studies, the number of women giving birth over the age of 35 has increased by 23.3% in the last decade. This demographic shift has led to a surge in demand for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Moreover, the market is also influenced by the growing incidence of prostate cancer, which can impact male fertility. According to the American Cancer Society, there will be approximately 193,000 new cases of prostate cancer diagnosed in the US in 2022.
This statistic underscores the importance of fertility services in addressing the reproductive health needs of cancer survivors. Despite these growth opportunities, the market faces challenges, including high complication rates associated with fertility treatments. For instance, the risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) are significant concerns. These complications can lead to increased healthcare costs and potential long-term health risks for patients. The market is a complex and dynamic industry, shaped by demographic trends, health concerns, and technological advancements. As the demand for fertility treatments continues to rise, stakeholders must navigate the challenges and opportunities that come with this evolving landscape.

Major Market Trends & Insights

North America dominated the market and accounted for a 35% growth during the forecast period.
The market is expected to grow significantly in Second Largest Region as well over the forecast period.
By the Service, the Treatment services sub-segment was valued at USD 6.65 billion in 2023
By the End-user, the Fertility clinics sub-segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 89.23 billion
Future Opportunities: USD USD 9.53 billion 
CAGR : 7.8%
North America: Largest market in 2023

What will be the Size of the Fertility Services Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

Fertility services encompass a range of medical interventions and technologies designed to help individuals and couples achieve pregnancy. One significant area within this market is the use of fertility medications, which play a crucial role in assisted reproductive technology (ART). According to recent reports, approximately 12% of women in the United States have used some form of fertility medication. ART involves various techniques, including artificial insemination, ovulation predictor kits, and ovarian stimulation protocols, among others. Cervical mucus plays a vital role in the natural process of conception, but ART may bypass this step through the use of intrauterine insemination (IUI) or in vitro fertilization (IVF).
In IUI, semen cryopreservation is essential for the success of the procedure. Ovarian stimulation protocols, such as ovulation induction, are commonly used in ART to increase the number of mature follicles and improve the chances of successful pregnancy. Ovulation predictor kits help individuals monitor their menstrual cycle and identify the most fertile days for conception. Despite the advancements in fertility services, challenges persist. Miscarriage rates remain a concern, with approximately 10-20% of known pregnancies ending in miscarriage. Blastocyst development is a critical factor in the success of ART, with implantation rate and pregnancy rate being essential indicators of treatment efficacy.
Reproductive endocrinology, a subspecialty of obstetrics and gynecology, focuses on the diagnosis and treatment of infertility. Donor insemination and ectopic pregnancy are other areas of fertility services that have gained increasing attention. Embryo culture media and ultrasound imaging are essential tools used in the field to monitor the development of embryos and assess the progress of pregnancies. Looking ahead, the market is expected to grow substantially. According to market reports, the global ART market is projected to expand at a significant rate, with an increase of around 15% in the number of ART cycles performed annually.
This growth is driven by factors such as rising infertility rates, increasing awareness, and advancements in technology. Comparing the growth rates of different regions, Asia Pacific is expected to witness the fastest growth in the ART market due to factors such as increasing disposable income, changing social norms, and government initiatives to promote fertility treatments

Today, globally, women of childbearing age have an average of approximately 2.2 children over the course of their lifetime. In pre-industrial times, most women could expect to have somewhere between five and ten live births throughout their lifetime; however, the demographic transition then sees fertility rates fall significantly. Looking ahead, it is believed that the global fertility rate will fall below replacement level in the 2050s, which will eventually lead to population decline when life expectancy plateaus. Recent decades Between the 1950s and 1970s, the global fertility rate was roughly five children per woman - this was partly due to the post-WWII baby boom in many countries, on top of already-high rates in less-developed countries. The drop around 1960 can be attributed to China's "Great Leap Forward", where famine and disease in the world's most populous country saw the global fertility rate drop by roughly 0.5 children per woman. Between the 1970s and today, fertility rates fell consistently, although the rate of decline noticeably slowed as the baby boomer generation then began having their own children. Replacement level fertility Replacement level fertility, i.e. the number of children born per woman that a population needs for long-term stability, is approximately 2.1 children per woman. Populations may continue to grow naturally despite below-replacement level fertility, due to reduced mortality and increased life expectancy, however, these will plateau with time and then population decline will occur. It is believed that the global fertility rate will drop below replacement level in the mid-2050s, although improvements in healthcare and living standards will see population growth continue into the 2080s when the global population will then start falling.

Snapshot img

Artificial Insemination Market -Forecast and Analysis 2021-2025

The artificial insemination market is experiencing robust growth, driven by rising infertility rates, advancements in reproductive technologies, and increasing societal acceptance of assisted reproductive techniques. Valued at USD 1.45 billion in 2020, the market is projected to grow by USD 778.33 million, reaching USD 2.23 billion by 2025, with a compound annual growth rate (CAGR) of 6.59%. From fertility centers in the United States to home-based solutions in Europe, artificial insemination is transforming family planning and reproductive healthcare. This in-depth analysis explores the drivers, segments, trends, challenges, and recent developments shaping the artificial insemination market, spotlighting key players like Vitrolife AB, Genea Limited, and CooperSurgical Inc., and providing actionable insights for stakeholders in this evolving industry.

What will the Artificial Insemination Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Artificial Insemination Market Size for the Forecast Period and Other Important Statistics

Key Drivers of the Artificial Insemination Market

A dynamic combination of factors is propelling the artificial insemination market, cementing its role in modern reproductive healthcare:

Rising Infertility Rates: With global infertility affecting over 15% of couples, demand for artificial insemination is surging, particularly in the US and China, where lifestyle factors and delayed pregnancies are prevalent.
Technological Advancements: Innovations in sperm preparation and intrauterine insemination (IUI) techniques, led by companies like Vitrolife, improve success rates, driving adoption in Europe and Asia-Pacific.
Growing Acceptance of ART: Increasing societal openness to assisted reproductive technologies (ART), including same-sex and single-parent families, boosts demand in Australia and Canada.
Supportive Regulations: Favorable policies in countries like the UK and India, including insurance coverage for fertility treatments, encourage market growth.
Rising Awareness: Educational campaigns in Brazil and South Africa are increasing awareness of artificial insemination, expanding access in emerging markets.

Case Study: Enhancing Success Rates in California

A California-based fertility center adopted Vitrolife's advanced sperm preparation kits, improving IUI success rates by 20%. The technology's precision in selecting viable sperm streamlined procedures, helping more couples achieve successful pregnancies and showcasing artificial insemination's transformative potential.

Market Segmentation: A Detailed Breakdown

The artificial insemination market is diverse, segmented by end-user and geography, each contributing to its robust growth. Here's an in-depth analysis for 2021–2025:

By End-user

Fertility Centers: Fertility centers are the primary hubs for artificial insemination, offering specialized procedures like IUI and intracervical insemination (ICI). Equipped with advanced technologies, these centers cater to diverse patients, including heterosexual couples and same-sex partners, particularly in the US and Europe. They provide comprehensive services, from sperm analysis to hormonal treatments, ensuring high success rates. The rise of medical tourism in countries like India fuels demand for these facilities. Ongoing investments in infrastructure drive their dominance in the market.
Home: Home-based artificial insemination is gaining traction, driven by DIY kits and telemedicine platforms, especially in Europe and Australia. These kits, offered by companies like Mosie Baby, allow couples to perform ICI at home, increasing accessibility and privacy. Growing awareness and online support communities enhance adoption. However, success rates depend on user expertise and sperm quality. The convenience of home solutions appeals to cost-conscious and rural populations.
Others: This segment includes hospitals, gynecology clinics, and research institutions offering artificial insemination services. In Asia-Pacific, hospitals integrate IUI with broader reproductive care, serving urban populations. Research institutions in Canada explore advanced techniques like sperm sorting for genetic screening. These facilities cater to niche needs, such as donor insemination for single parents. Their role is expanding as ART becomes more mainstream.

What are the Revenue-generating End-user Segments in the Artificial Insemination Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

By Geography

North America: North America, led by the US and Canada, is a key market due to high infertility rates and advanced healthcare infrastructure. The US sees strong demand in fertility centers, driven by companies like CooperSurgical offering IUI solutions. Canada's supportive policies fo

The fertility pregnancy rapid test kits market is expected to witness stable growth, with global sales projected to reach USD 1.60 billion in 2025. This reflects an increase from an estimated USD 1.5 billion in 2024. By 2035, the market is forecasted to expand to USD 2.49 billion, registering a CAGR of 4.5%.

Attributes	Key Insights
Historical Size, 2024	USD 1.5 billion
Estimated Size, 2025	USD 1.60 billion
Projected Size, 2035	USD 2.49 billion
Value-based CAGR (2025 to 2035)	4.5%

Semi Annual Market Update

Particular	Value CAGR
H1	5.2% (2024 to 2034)
H2	4.9% (2024 to 2034)
H1	4.5% (2025 to 2035)
H2	4.0% (2025 to 2035)

Analyzing Fertility Pregnancy Rapid Test Kits Market Market by Top Investment Segments

By Product	Value Share (2025)
Pregnancy Rapid Tests	57.0%

By Test Type	Value Share (2025)
hCG Urine	45.3%

Country-wise Insights

Countries	Value CAGR (2025 to 2035)
United States	3.8%
Germany	4.8%
Italy	3.6%
UK	4.5%
China	6.9%
India	6.6%
Japan	5.0%

Surrogacy Market Outlook

The global surrogacy market size was valued at approximately USD 14.5 billion in 2023 and is projected to reach nearly USD 30 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period. This growth can be attributed to several factors including increasing infertility rates, advancements in reproductive technologies, and a growing acceptance of diverse family structures. The demand for surrogacy services is being driven by both medical advancements and societal changes, leading to a steadily increasing market size over the coming years.

One of the primary growth factors for the surrogacy market is the rising incidence of infertility worldwide. Factors such as lifestyle changes, delayed childbearing, and increased prevalence of health conditions like polycystic ovarian syndrome (PCOS) and endometriosis contribute to infertility rates, thereby driving demand for alternative reproductive solutions like surrogacy. Additionally, advancements in reproductive technologies have made surrogacy a more viable and successful option for many couples. Techniques such as in vitro fertilization (IVF) have improved success rates and made surrogacy a more attractive option for families seeking to have children. Furthermore, legislative changes in various regions have facilitated the growth of the surrogacy market by providing clearer guidelines and protections for all parties involved in the surrogacy process.

Societal acceptance of diverse family structures, including same-sex couples and single parents, has significantly contributed to the growth of the surrogacy market. As cultural and social norms evolve, there is increasing recognition and support for the rights of individuals and couples to have a family through surrogacy. This shift in societal attitudes is further supported by the media, which often highlights stories of families formed through surrogacy, thereby increasing awareness and acceptance. Additionally, celebrities and public figures openly embracing surrogacy have also played a role in normalizing the practice and encouraging others to consider it as a viable option for family building.

The regional outlook for the surrogacy market shows significant growth potential across different geographic areas. North America, particularly the United States, remains a leading market due to its advanced healthcare infrastructure, favorable legal frameworks, and high awareness and acceptance levels of surrogacy. Europe is also witnessing growth, driven by countries like the United Kingdom and Ukraine, which have established regulations supporting surrogacy arrangements. The Asia Pacific region is anticipated to experience the highest growth rate due to increasing medical tourism, relatively lower costs, and favorable government initiatives. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as key markets due to improving healthcare systems and growing acceptance of surrogacy solutions.

Type Analysis

In the surrogacy market, the primary types include gestational surrogacy and traditional surrogacy. Gestational surrogacy, where the surrogate carries a child genetically unrelated to her, has become the most popular choice due to its clear legal framework and widespread acceptance. This type of surrogacy minimizes emotional and legal complexities, as the surrogate has no genetic ties to the child. Advances in IVF technology have further facilitated gestational surrogacy, making it a preferred option for many. On the other hand, traditional surrogacy, where the surrogate is also the biological mother, is less common due to potential legal and emotional complications. Nonetheless, it remains an option for individuals or couples who might not have other alternatives due to specific medical conditions.

Gestational surrogacy is particularly attractive to intended parents due to its potential for higher success rates and the legal clarity it offers. In many regions, gestational surrogacy is considered more socially acceptable, as it aligns with the preference for the surrogate not having a biological connection to the child. This preference is reflected in the growing number of fertility clinics and surrogacy agencies specializing in gestational surrogacy services. Additionally, advancements in pre-implantation genetic screening and other reproductive technologies have improved the likelihood of successful pregnancies in gestational surrogacy, further fueling its demand.

Traditional surrogacy, despite being less prevalent, remains an important segment of the market. It is often considered by

Sex ratio at birth (male births per female births) in United States was reported at 1.049 in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Sex ratio at birth (male births per female births) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The global infertility drugs market is estimated to reach approximately XXX million by 2033, with a CAGR of XX% during the forecast period 2025-2033. The rising prevalence of infertility, increasing awareness about assisted reproductive technologies (ART), and technological advancements in drug development are the primary drivers of the market growth. Furthermore, government initiatives to promote fertility treatments and the increasing number of women delaying childbearing contribute to the market's expansion. Geographically, North America is projected to dominate the infertility drugs market, followed by Europe and Asia-Pacific. The United States holds a significant market share due to the high prevalence of infertility and the advanced healthcare system. Europe is another promising market, with countries such as Germany, France, and the United Kingdom being major contributors. The Asia-Pacific region is expected to witness significant growth in the coming years, driven by the increasing disposable income and the rising awareness about infertility treatments.

The durable baby goods stores industry faces significant challenges tied to historic low birth rates and shifting demographics. Data from the CDC reveals that in 2024, the US recorded 3,622,673 births, representing only a 1.0% climb from the previous year, with the fertility rate at 1.62 births per woman, significantly below the replacement level of 2.1. This has resulted in limited demand growth for big-ticket baby items, placing retailers under pressure to achieve sales growth. Changing family structures and preferences are diversifying and fragmenting the consumer base, adding unpredictability to demand. Through the five years to 2025, industry revenue has gained at a CAGR of 0.6% to $15.6 billion in 2025, including a 0.6% gain in 2025 alone. Retailers are pivoting to cope with these challenges. Differentiating their offerings through enhancing safety, sustainability and smart technology features is a popular tactic. Retailers have taken measures such as expanding their baby and toddler segment with more affordable products, improving their baby registry program and offering exclusive deals. Simultaneously, product innovation is reshaping the industry with a surge in demand for eco-friendly materials, smart technology integration and customizable solutions. The expansion of e-commerce has also heightened industry competition, forcing many retailers to invest significantly in seamless online experiences and personalized marketing strategies. Heightened competition has caused profit to stagnate, reaching 4.1% in 2025. The fertility rate is projected to continue its gradual drop, making strategic innovation and brand loyalty cultivation even more crucial for retailers. Social media will emerge as a potent influence, shaping industry trends and consumer preferences whilst creating direct engagement opportunities for brands. As such, a more integrated use of social media in brand strategy will be vital. With growing household incomes and a more discerning consumer base, premiumization will become a more prominent trend in the industry, primarily focusing on safety, sustainability and superior quality. Simultaneously, as consumer preference for online shopping grows, online sales of baby products are expected to surge, creating opportunities and competition for established and direct-to-consumer brands. Industry revenue will climb at an estimated CAGR of 1.7% to $17.0 billion in 2030.

Snapshot img

Assisted Reproductive Technology Market Size 2024-2028

The assisted reproductive technology (ART) market size is forecast to increase by USD 6.3 billion at a CAGR of 4.36% between 2023 and 2028.

The market is experiencing significant growth due to the increasing rate of infertility cases, fertility supplements and the rising number of single-parent families. Infertility affects approximately 15% of couples worldwide, and this number is projected to increase. Additionally, the trend of single parenthood is on the rise, with over 30 million single parents in the United States alone. These demographic shifts are driving the demand for ART solutions, as they offer a viable option for individuals and couples seeking to start a family. However, the ART market also faces challenges. Side effects of infertility treatments, such as multiple pregnancies, ovarian hyperstimulation syndrome, and emotional stress, can deter potential patients.
These risks, coupled with the high cost of treatments, can limit market penetration. It is crucial for market players to address these challenges by investing in research and development of safer and more affordable ART solutions. By focusing on improving patient outcomes and reducing the financial burden, companies can capitalize on the growing demand for ART services and maintain a competitive edge in this dynamic market.

What will be the Size of the Assisted Reproductive Technology (ART) Market during the forecast period?

Request Free Sample

The market dynamics continue to evolve, driven by advancements in reproductive medicine and the expanding application across various sectors. Infertility treatment, a significant market segment, integrates ovulation induction, third-party reproduction, and hormonal therapy. Fertility preservation, another evolving area, encompasses donor eggs, egg retrieval, and embryo culture, catering to individuals undergoing medical treatments or choosing to delay parenthood. Stress and infertility are increasingly recognized as interconnected, leading to a growing emphasis on lifestyle modifications. Reproductive health concerns, such as chromosomal abnormalities and single gene disorders, are addressed through advanced diagnostic tools and reproductive surgery. Male infertility, a prevalent issue, is addressed through assisted hatching and sperm analysis.
Fertility clinics, reproductive centers, and fertility specialists leverage ART technologies to provide comprehensive services, including infertility testing diagnosis, fertility medications, and embryo transfer. Fertility apps and tracking tools facilitate patient engagement and support, while reproductive endocrinology continues to unravel the complexities of human reproduction. Environmental toxins and age-related infertility are emerging challenges, prompting ongoing research in stem cell research and reproductive medicine. The market landscape remains dynamic, with ongoing advancements in ART technologies and applications, ensuring a continuous unfolding of market activities.

How is this Assisted Reproductive Technology (ART) Industry segmented?

The assisted reproductive technology (ART) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-User

  Fertility clinics
  Hospitals
  Surgical centers
  Research institutes/labs
  Cryobanks


Type

  IVF
  Artificial Insemination
  GIFT (Gamete Intrafallopian Transfer)
  ZIFT (Zygote Intrafallopian Transfer)
  Surrogacy
  Donor egg/sperm ART


Product

  Instrument
  Accessory and Disposable
  Reagents and Media
  Software


Geography

  North America

    US


  Europe

    France
    Germany
    Netherlands
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-User Insights

The fertility clinics segment is estimated to witness significant growth during the forecast period.

Request Free Sample

Fertility clinics lead the assisted reproductive technology (ART) market, driven by a global surge in fertility centers addressing the rising demand from infertility patients. The success rates of these clinics measured by pregnancies or live births per treatment annually-are pivotal, boosting their reputation as top fertility treatment destinations in both domestic and international markets. Enhanced infrastructure in fertility clinics supports medical tourism for infertility treatment and drug though demand fluctuates due to economic factors, exchange rates, and external factors during 2025-2029. Organizations like ESHRE, ASRM, and ICMART work to standardize fertility tourism, minimizing exploitation and risks. However, stringent regulations pose challenges, with non-compliance le

Market Analysis The global baby milk powder market is estimated to reach a size of USD XXX million by 2033, growing at a CAGR of XX% from 2025 to 2033. The increasing birth rate, rising disposable income, and growing awareness about infant nutrition are driving market growth. The rapid urbanization and changing lifestyle trends are further contributing to the demand for convenient and nutritious baby milk powder. However, the high cost of premium brands and concerns over potential health risks associated with artificial formulas are restraining market growth. Segmentation and Regional Analysis Based on application, the market is divided into infant formula, follow-on formula, and toddler formula. Infant formula holds the largest market share due to the increasing number of working mothers and the perceived health benefits of breast milk substitutes. Based on type, the market is segmented into organic, conventional, and specialty formulas. Organic baby milk powder is gaining popularity due to growing consumer awareness about health and environmental concerns. In terms of region, Asia Pacific dominates the market, followed by North America and Europe. China, India, and the United States are the key markets in these regions, with rapidly growing birth rates and rising disposable income. The global baby milk powder market is projected to reach a value of USD 85,740 million by 2028, expanding at a CAGR of 6.4% over the forecast period (2023-2028). The market is driven by factors such as rising birth rates, increasing disposable incomes, and growing awareness of the importance of nutrition for infants.

It is projected that the market would grow from USD 90.2 million in 2025 to USD 146.9 million in 2035, at a CAGR of 5.0% during the forecast period.

Market Metrics

Metric	Value
Market Size (2025E)	USD 90.2 Million
Market Value (2035F)	USD 146.9 Million
CAGR (2025 to 2035)	5.0%

Country-wise Insights

Country	CAGR (2025 to 2035)
United States	5.0%

Country	CAGR (2025 to 2035)
United Kingdom	5.0%

Country	CAGR (2025 to 2035)
European Union	5.0%

Country	CAGR (2025 to 2035)
Japan	5.0%

Country	CAGR (2025 to 2035)
South Korea	5.0%

Segmentation Outlook

Product Type	Market Share
Tri-gas Incubators with Camera	54.6%

End User	Market Share
Fertility Clinics	59.8%

Competitive Outlook

Company Name	Estimated Market Share (%)
Esco Micro Pte. Ltd.	20-24%
Vitrolife AB	18-22%
Genea Biomedx	15-18%
Cook Medical Inc.	10-13%
Other Companies (combined)	28-32%

The global human chorionic gonadotropin (hCG) market is projected to reach USD 2.65 billion by 2033, expanding at a CAGR of 3.17% from 2025 to 2033. Rising prevalence of infertility, increasing adoption of assisted reproductive technologies, and advancements in hCG manufacturing methods are key drivers fostering market growth. Infertility treatment and ovulation induction account for the major share of the market. Regional analysis reveals that North America dominates the market, followed by Europe and Asia Pacific. The United States contributes significantly to the North American market due to high healthcare expenditure, rising adoption of IVF procedures, and presence of leading healthcare providers. Europe also holds a sizable share owing to favorable reimbursement policies and increasing fertility rates. Asia Pacific is witnessing substantial growth due to rising disposable income, growing awareness about infertility, and increasing healthcare infrastructure. Key players in the hCG market include Ferring Pharmaceuticals, Hetero Labs, Merck, LG Chem, and Organon Co. Recent developments include: The rising prevalence of infertility and the increasing adoption of assisted reproductive technologies are key factors driving market growth., Additionally, advancements in HCG production and purification techniques have improved the availability and affordability of HCG products, further contributing to market expansion. Recent news developments include the launch of new HCG formulations, such as long-acting injectables, which offer improved patient convenience and compliance., The market is also witnessing increased research and development activities focused on developing novel HCG-based therapies for various indications.. Key drivers for this market are: Increased fertility treatment Rising demand for assisted reproductive technologies Growing prevalence of infertility Expansion of healthcare infrastructure Advanced research and development initiatives. Potential restraints include: Technological advancements Growing demand for fertility treatments Rising incidence of infertility Government initiatives and regulations Increasing healthcare expenditure.